Friday 6-13-2014 Nasdaq Biotechnology Ishares (IBB) $IBB

New Post Public Reply Private Reply Replies (0) Message Board
Lucky Jimmy
Friday 6-13-2014 Nasdaq Biotechnology Ishares (IBB) $IBB opened at 248.25 hitting the high price of 248.91 and a day low of 245.17 with a total volume of 957,243. IBB had a previous close of 247.83 and has been seeing an average volume of 1,059,430.

Overall Average: 64% Buy

Recent stock forum discussions about IBB http://investorshangout.com/search?q=IBB&...mp;yt0=Go!

Two Biotech ETFs Surge on Idenix-Merck Deal - ETF News And Commentary
Sweta Killa - ZACKS - Tue Jun 10, 1:00PM CDT
Idenix Pharmaceuticals pushes these two biotech ETFs higher ahead of the rivals on Merck buyout. (full story)

Jim Cramer's 'Mad Money' Recap: Fewer Jobs = Bull Market
at The Street - Wed Jun 04, 7:10PM CDT
Disbelief is a hallmark of a powerful bull market, Cramer says. Nowhere is that disbelief stronger than in the notion that fewer jobs are better for stock prices. (full story)

iShares Nasdaq Biotechnology Index Rises 1.06% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Wed Jun 04, 3:55PM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $239.34 to a high of $243.72. Yesterday, the shares gained 1.1%, which took the trading range above the 3-day high of $241.59 on volume of 906,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious. (full story)

Look Abroad When You Have an American Trendless Market
at The Street - Tue Jun 03, 1:11PM CDT
You can't judge this market by the headlines. But India is showing much greater potential. (full story)

A Comprehensive Guide to Biotech ETFs - ETF News And Commentary
Zacks Equity Research - ZACKS - Fri May 30, 7:00AM CDT
Despite recent volatility in the space, the longer-term fundamentals remain attractive. (full story)

SmarTrend Watching for Potential Pullback in Shares of iShares Nasdaq Biotechnology Index After 2.48% Gain
Comtex SmarTrend(R) - Tue May 27, 4:18PM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $236.60 to a high of $240.68. Yesterday, the shares gained 2.5%, which took the trading range above the 3-day high of $236.28 on volume of 1.4 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious. (full story)

After Yesterday's Rally of 2.48% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Tue May 27, 4:17PM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $236.60 to a high of $240.68. Yesterday, the shares gained 2.5%, which took the trading range above the 3-day high of $236.28 on volume of 1.4 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious. (full story)

iShares Nasdaq Biotechnology Index Fund (IBB) : Stop activated ($239.00)
Trading Central - Tue May 27, 10:00AM CDT
The ETF has reached our stop loss which was set at $239.00. Performance: -5.55%. Trading strategy: Stop activated ($239.00). (full story)

How Will Biotech Fare the Rest of the Year?
George Budwell, The Motley Fool - Motley Fool - Fri May 23, 5:30PM CDT
Biotech has had a fairly volatile year thus far. Shares of the closely watched iShares Nasdaq Biotech Index , for instance, have swung from double-digit gains to high single-digit losses at one point this year. With the index now roughly flat for... (full story)

iShares Nasdaq Biotechnology Index Set to Possibly Pullback After Yesterday's Rally of 1.92%
Comtex SmarTrend(R) - Thu May 22, 3:43PM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $229.00 to a high of $236.28. Yesterday, the shares gained 1.9%, which took the trading range above the 3-day high of $231.96 on volume of 1.6 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious. (full story)

iShares Nasdaq Biotechnology Index Fund (IBB) : Short Sell @ $226.44
Trading Central - Thu May 15, 10:33AM CDT
From a technical view, the ETF is shaping a symmetrical triangle calling for the continuation of the previous bearish trend. Regarding technical indicators, the daily MACD is facing a strong resistance area while the daily RSI is reversing down from... (full story)

R.I.P. the Momentum Trade, 2012-2014
at The Street - Tue May 13, 1:39PM CDT
The momentum trade is dead. And a new momentum trade has risen to take its place. (full story)

iShares Nasdaq Biotechnology Index Fund (IBB) : Close former position at last price ($232.50)
Trading Central - Tue May 13, 9:10AM CDT
On a relative basis against the IVV S&P500, the iShares Nasdaq Biotechnology Index Fund is losing upward momentum since it is reversing down from a bearish trend line; we prefer to close our long position opened on April 22nd. Trading strategy: ... (full story)

Watch for iShares Nasdaq Biotechnology Index to Potentially Pullback After Gaining 2.42% Yesterday
Comtex SmarTrend(R) - Mon May 12, 4:06PM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $227.09 to a high of $232.40. Yesterday, the shares gained 2.4%, which took the trading range above the 3-day high of $231.14 on volume of 1.8 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious. (full story)

Look for Shares of iShares Nasdaq Biotechnology Index to Potentially Pullback after Yesterday's 2.42% Rise
Comtex SmarTrend(R) - Mon May 12, 4:03PM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $227.09 to a high of $232.40. Yesterday, the shares gained 2.4%, which took the trading range above the 3-day high of $231.14 on volume of 1.8 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious. (full story)

Growth Correction Over - Real Time Insight
Kevin Cook - Zacks Investment Research - Mon May 12, 2:00PM CDT
Where are you finding GARP now? (full story)

iShares Trust Nasdaq Biotech Index Fund (IBB) Stock Research Links

IBB Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Greenberg Traurig's Brad Kaufman: A Mentor of Resolute Impact

Updated Category News Views 214

A Milestone for Mentorship at Greenberg Traurig In the often cutthroat jungle of law, finding someone who actually gives a damn about you is as rare as finding a unicorn. Yet, there it is—Brad Kaufman, at the helm of Greenberg Traurig's professional development, proving that mentorship can be more than just a checkbox on a quarterly review. Award for Exceptional...

Continue Reading
SDI Presence Marks 30 Years with Top Workplace Honor

Updated Category News Views 148

30 Years of Innovation and Recognition If you've been around the block like I have, you know that anniversaries in the corporate world are more than just cake and confetti. For SDI Presence, hitting their 30th year alongside a ninth consecutive Chicago Tribune Top Workplaces recognition smacks of substance and staying power. These folks aren’t just resting on their...

Continue Reading
Dana Concludes Tender Offers for Senior Notes

Updated Category News Views 124

An Investor's Glance at Dana's Strategic Moves Dana Incorporated (NYSE: DAN) just pulled a bold move with their tender offers, snapping up a hefty $357,873,000 in outstanding principal on their senior notes. This isn’t just pocket change; folks holding out for securities can feel the tension of watching big numbers get shuffled around. You gotta wonder, what's the play...

Continue Reading
CARsgen's CAR-T Breakthrough on China's Insurance List

Updated Category News Views 81

A Game Changer for CAR-T Therapies There's a breeze of optimism blowing from Shanghai these days—a rare sensation in this market of endless skirmishes. CARsgen Therapeutics Holdings Limited, a company entrenched in the development of cutting-edge CAR T-cell therapies, just notched a victory. They've announced that their CAR T-cell therapy product, satricabtagene...

Continue Reading
GTEC Faces Nasdaq Bid Price Compliance Challenge

Updated Category News Views 127

Greenland Technologies in a Tight Spot Man, stocks can be as unpredictable as a cat on a hot tin roof, and Greenland Technologies Holding Corporation (Nasdaq: GTEC) just got a cold splash of reality from Nasdaq. On November 10, 2026, they were handed a Notification Letter that ain’t exactly a love note. Their shares slipped below the one-buck hurdle, and Nasdaq isn’t...

Continue Reading
BTQ Technologies Calls Investors for Key Quantum Update

Updated Category News Views 107

You know what's stirring the pot over at BTQ Technologies? A shareholder call coming up soon, and boy, it's got 'eye-opening insights' written all over it. We're talkin' Q3 financial results and, likely, a smattering of future plans on the quantum front, folks. Diving into BTQ's Quantum Vision BTQ Technologies Corp. (NASDAQ: BTQ) isn't just another tech firm banging on...

Continue Reading
Terra Kaffe's Big Win with Oprah's Endorsement

Updated Category News Views 98

Terra Kaffe Hits the Jackpot with Oprah Sometimes, destiny has a way of handing out golden tickets, and for Terra Kaffe, receiving a nod from Oprah Winfrey's revered list of Favorite Things for 2026 is nothing short of that. I mean, you can't underestimate the pull Mrs. O has. Her endorsement isn’t just another celebrity pat-on-the-back, it’s a megaphone blaring...

Continue Reading
Enjay Acquires New Method: A Strategic Synergy Unfolds

Updated Category News Views 105

Enjay's Bold Move into New Territory Here's a headline that doesn’t just flutter past like yesterday's news. Enjay Converters Ltd, straight from Cobourg, Ontario, has clinched a deal that looks like it might just shake things up a bit on the food packaging scene. They’ve bagged New Method Packaging LLC, another big player, but this time from the heartland of...

Continue Reading
HNTB Partners with Kansas City Chiefs for New Stadium

Updated Category News Views 103

A New Chapter for the Kansas City Chiefs Are we witnessing the dawn of a new era for the Kansas City Chiefs? Officially naming HNTB as the architect for their upcoming stadium signals a strategic pivot, aimed at not just snagging eyeballs, but embedding Kansas City deeper into the sports architecture hall of fame. Unveiled during the Power Brokers Sports-Anchored...

Continue Reading
Wiz Khalifa Ignites MJBizCon 2026 with Keynote and Music

Updated Category News Views 161

An Icon in Cannabis Culture Hits the Stage When you mix business with pleasure, you get something like what MJBizCon's cooking up this year. Wiz Khalifa, the man with a knack for turning passion into profit, is jumping onto the stage—not just as a performer, but also as a keynote speaker. On December 2, attendees are in for a treat as he steps into a new spotlight at...

Continue Reading

Top 5 Most Recently Viewed Articles

Matinas BioPharma Welcomes New Board Member and Funding Deal

Updated Category News Views 163

Introduction to Recent Developments at Matinas BioPharma Matinas BioPharma Holdings, Inc. (NYSE American: MTNB) is making headlines with its latest announcement about a major agreement involving the acquisition of preferred stock and the appointment of a new board member. This strategic move promises to bolster the company's position as a leading biopharmaceutical entity...

Continue Reading
Forecasting the Future of Intelligent Transportation Systems

Updated Category News Views 218

Understanding the Intelligent Transportation System Market The intelligent transportation system (ITS) market is on track to achieve remarkable growth, with an estimated value of USD 55.36 billion anticipated in the coming years. This growth marks an increase from USD 42.55 billion in recent years, demonstrating a compound annual growth rate (CAGR) of 5.4% as per the...

Continue Reading
Revolutionizing Hospitality: Experience the Future with AI

Updated Category News Views 128

Transforming the Hotel Experience with AI Hotels today have evolved far beyond basic digital solutions like QR codes to access menus. The landscape is shifting, and at the forefront of this change is Product Genius, a platform that harnesses the power of AI to revolutionize guest interactions. With its advanced features, Product Genius provides hotels with a way to...

Continue Reading
Champions Oncology Reaches New Heights with Stock Surge

Updated Category News Views 126

Champions Oncology Stock Experiences Remarkable Growth Champions Oncology, Inc. (NASDAQ: CSBR) has recently reached an impressive milestone in its stock performance, hitting a new 52-week high of $9.94. This surge comes alongside significant advancements in the company’s market capitalization, currently standing at approximately $133 million, with an annual revenue of...

Continue Reading
Investor Alert: Protect Your Rights with iLearningEngines, Inc.

Updated Category News Views 93

Protecting Investor Rights: Insights into iLearningEngines, Inc. iLearningEngines, Inc. (NASDAQ: AILE) is under significant scrutiny due to claims that may impact its investors. The Rosen Law Firm is currently investigating these situations, emphasizing the importance for shareholders to be informed and proactive regarding their rights. Understanding the Allegations There...

Continue Reading